Pancreatic Cancer Research

ResearcherHeilongjiang University of Chinese MedicineActive in the last 2 years

XiaoQing You

Matched on ORCID iD 0000-0002-8245-8263.

Their work

Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.

Pancreatic cancer papers
1 (first author 0, last author 1)
Pancreatic cancer trials
0
Pancreatic cancer grants
0
Collaborators
1
Papers, trials and grants by year

2025: 1 paper

Papers 1

  1. LncRNA ROR1-AS1 Stimulates Epithelial-Mesenchymal Transition and Chemoresistance of Pancreatic Cancer by Upregulating HMGB1 Through miR-33a-5p Adsorption. Last author DOI 10.1002/jbt.70499↗

Closest collaborators

The 1 strongest of 1 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

  1. Renzhe Tang · 1 shared paper, 2025

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.